References
- Jorge AJL, Cordeiro JR, Rosa MLG, et al. Vitamin D Deficiency and
Cardiovascular Diseases. Int. J. Cardiovasc. Sci. Aug
2018;31(4)422-432
https://doi.org/10.5935/2359-4802.20180025.
- Nibbelink KA, Tishkoff DX, Hershey SD, et al. 1,25(OH)2-vitamin D3
actions on cell proliferation, size, gene expression, and receptor
localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol
2007;103:533–537.
- Wu-Wong JR, Nakane M, Ma J, et al. Effects of Vitamin D analogs on
gene expression profiling in human coronary artery smooth muscle
cells. Atherosclerosis 2006 May;186(1):20–8.
- Merke J, Milde P, Lewicka S, et al. Identification and regulation of
1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of
1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic
endothelial cells and human dermal capillaries. J Clin Invest 1989
Jun;83(6):1903–15.
- Cantorna MT, Mahon BD. D-hormone and the immune system. J Rheumatol
Suppl. 2005;76:11-20.
- Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine
regulator of the rennin-angiotensin system and blood pressure. J
Steroid Biochem Mol Biol. 2004 May;89-90(1-5):387-92.
- Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer:
potential for anticancer therapeutics. Nat Rev Cancer. 2007
Sep;7(9):684-700.
- Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of
cardiovascular disease. Circulation. 2008 Jan 29;117(4):503-11.
- Lee JH, Keefe JHO, Bell D, et al. Vitamin D deficiency an important,
common, and easily treatable cardiovascular risk factor? J Am Coll
Cardiol. 2008 Dec 9;52(24):1949-56.
- Kheiri B, Abdalla A, Osman M, et al. Vitamin D deficiency and risk of
cardiovascular diseases: a narrative review. Clin Hypertens. 2018 Jun
22;24:9.
- Mithal A, Wahl DA, Burckhardt P, et al. Global vitamin D status and
determinants of hypovitaminosis D. Osteoporos Int. 2009
Nov;20(11):1807–20.
- Van Ballegooijen AJ, Kestenbaum B, Sachs MC, et al. Association of
25-hydroxyvitamin D and parathyroid hormone with incident
hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll
Cardiol. 2014 Apr 1;63(12):1214-22.
- McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med.
2010 Jan 21;362(3):228–38.
- Gullestad L, Ueland T, Vinge LE, et al. Inflammatory cytokines in
heart failure: mediators and markers. Cardiology. 2012;122(1):23–35.
- Yuan W, Pan W, Kong J, et al. 1,25-dihydroxyvitamin D3 suppresses
renin gene transcription by blocking the activity of the cyclic AMP
response element in the renin gene promoter. J Biol Chem. 2007 Oct
12;282(41):29821-30.
- Connell JM, Mackenzie SM, Freel EM, et al. A lifetime of aldosterone
excess: long-term consequences of altered regulation of aldosterone
production for cardiovascular function. Endocr. Rev. 2008 Apr;
29(2):133-54.
- Sunbul M, Bozbay M, Mammadov C, et al. Effect of vitamin D deficiency
and supplementation on myocardial deformation parameters and
epicardial fat thickness in patients free of cardiovascular risk. Int
J Cardiovasc Imaging. 2015 Apr;31(4):765-72.
- Omidi F, Hosseinsabet A. Is the longitudinal deformation of the left
ventricle affected by vitamin D deficiency in nondiabetics? A 2D
speckle-tracking echocardiographic study. Echocardiography. 2019
Jan;36(1):67-73.
- Davarpasand T. Vitamin D deficiency as a seed in a fertile soil: A
proposed hypothesis. Echocardiography. 2019 May;36(5):1019.
- Gómez-Alonso C, Naves-Díaz ML, Fernández-Martín JL, et al. Vitamin D
status and secondary hyperparathyroidism: the importance of
25-hydroxyvitamin D cut-off levels. Kidney Int Suppl. 2003
Jun;(85):S44-8.
- Terrovitis J, Zotos P, Kaldara E, et al. Bone mass loss in chronic
heart failure is associated with secondary hyperparathyroidism and has
prognostic significance Eur J Heart
Fail. 14(3):326-32
- Schillaci G, Pucci G, Pirro M, et al. Large-artery stiffness: A
reversible marker of cardiovascular risk in primary
hyperparathyroidism. Atherosclerosis, 2011;218:98-101
- Rosa J, Raska I Jr, Wichterle D, et al. Pulse wave velocity in primary
hyperparathyroidism and effect of surgical therapy. Hypertens Res,
2011 Mar,34(3);296-300.
- Atasever A, Özdemir E, Acar T, et al. The effect of successful
parathyroid surgery on left ventricle function in patients with
primary hyperparathyroidism evaluated with strain echocardiography.
Echocardiography. 2020 May;37(5):670-677.
- Kırış A, Erem C, Kırış G, et al. The assessment of left ventricular
systolic asynchrony in patients with primary hyperparathyroidism.
Echocardiography. 2011 Oct;28(9):955-60.
- Smith JC, Page MD, John R, et al. Augmentation of central arterial
pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab,
2000 Oct;85(10):3515-9.
- Rothe HM, Liangos O, Biggar P, et al. Cinecalcet Treatment of primary
hyperparathyroidisim. Int J Endocrinol, 2011; 2011:415719.
- Pirro M, Manfredelli MR, Helou RS, et al. Association of parathyroid
hormone and 25-OH-vitamin D levels with arterial stiffness in
postmenopausal women with vitamin D insufficiency. J Atheroscler
Thromb. 2012;19(10):924-31.
- El Khoudary SR. Age at menopause onset and risk of cardiovascular
disease around the world. Maturitas. 2020 Nov;141:33-38.
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation,
treatment, and prevention of vitamin D deficiency: an Endocrine
Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011
Jul;96(7):1911–1930.
- Lang RM, Badano LP, Mor-avi V. et al. Recommendations for cardiac
chamber quantification by echocardiography in adults: an update from
the American Society of Echocardiography and the European Association
of Cardiovascular Imaging. J Am Soc Echocardiogr 2015
Jan;28(1):1–39.e14.
- Shingu Y, Amorim P, Nguyen TD, et al. Myocardial performance (Tei)
index is normal in diastolic and systolic heart failure induced by
pressure overload in rats, Eur J Echocardiogr, 2010
Dec;11(10):829-33.
- Tafreshi RI, Human N, Otukesh H, et al. Evaluation of combined left
ventricular function using the myocardial performance index in
children with chronic kidney disease. Echocardiography. 2011
Jan;28(1):97-103.
- Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to
identify subclinical vascular disease and evaluate cardiovascular
disease risk: a consensus statement from the American Society of
Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed
by the Society for Vascular Medicine. American Society of
Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc
Echocardiogr. 2008 Feb;21(2):93-111; quiz 189-90.
- Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the
ultrasound assessment of endothelial-dependent flow-mediated
vasodilation of the brachial artery: A report of the International
Brachial Artery Reactivity Task Force, J Am Coll Cardiol. 2002 Jan
16;39(2):257-65.
- Bots ML, Westerink J, Rabelink TJ, et al. Assessment of flow-mediated
vasodilatation (FMD) of the brachial artery: effects of technical
aspects of the FMD measurement on the FMD response, European Heart
Journal, Volume 26, Issue 4, February 2005, Pages 363–368.
- Holick MF (2006) High prevalence of vitamin D inadequacy and
implications for health. Mayo Clin Proc 2006 Mar;81(3):353-73.
- Saiki H, Kuwata S, Kurishima C, et al. Aldosterone-cortisol imbalance
immediately after Fontan operation with implications for abnormal
fluid homeostasis. Am J Cardiol 2014;114:1578–1583.
- Schnatz PF, Nudy M, Jiang X, et al. Vitamin D deficiency and
cardiovascular disease in postmenopausal women: contributions from
human and nonhuman primate studies. Menopause. 2015 May;22(5):554-63.
- Islam MZ, Viljakainen HT, Kärkkäinen MU, et al. Prevalence of vitamin
D deficiency and secondary hyperparathyroidism during winter in
premenopausal Bangladeshi and Somali immigrant and ethnic Finnish
women: associations with forearm bone mineral density. Br J Nutr. 2012
Jan;107(2):277-83.
- Pandit A, Mookadam F, Boddu S, et al. Vitamin D levels and left
ventricular diastolic function. Open Heart. 2014 Feb 15;1(1):e000011.
- Pilz S, Henry RM, Snijder MB, et al. Vitamin D deficiency and
myocardial structure and function in older men and women: the Hoorn
study. J Endocrinol Invest. 2010 Oct;33(9):612-7.
- Iqbal A, Jorde R, Lunde P, et al. Left ventricular dysfunction in
subjects with mild secondary hyperparathyroidism detected with pulsed
wave tissue Doppler echocardiography. Cardiology. 2006;105(1):1-8.
- Lim S, Shin H, Kim MJ, et al. Vitamin D inadequacy is associated with
significant coronary artery stenosis in a community-based elderly
cohort: the Korean Longitudinal Study on Health and Aging. J Clin
Endocrinol Metab. 2012 Jan;97(1):169-78.
- Zang L, Fu P, Huang YQ, et al. [Vitamin D deficiency and carotid
artery intima-media thickness and coronary calcification in patients
with diabetic nephropathy]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012
May;43(3):420-4, 450. Chinese.
- Ng YM, Lim SK, Kang PS, et al. Association between serum
25-hydroxyvitamin D levels and carotid atherosclerosis in chronic
kidney disease patients. BMC Nephrol. 2016 Oct 18;17(1):151.
- Costa AF, Barufaldi F, Silveira MA, et al. Association of PTH and
carotid thickness in patients with chronic kidney failure and
secondary hyperparathyroidism. J Bras Nefrol. 2014
Jul-Sep;36(3):315-9. English, Portuguese.
- Anderson JL, Vanwoerkom RC, Horne BD, et al. Parathyroid hormone,
vitamin D, renal dysfunction, and cardiovascular disease: dependent or
independent factors? Am Heart J 2011; 162:331–339.